KPC-000154

N/A

Report date: 2025/04/03 11:34:32
NME

Base Information

Drug NameKPC-000154
Drug Alias NameKPC000154KPC-000154
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor beta agonists
TargetsThyroid hormone receptor beta
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKpc Pharmaceuticals Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKunming Pharmaceutical Group (Zhuhai Hengqin) Technology Co LtdKpc Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A